Jump to main content
Jump to site search

Issue 2, 2015
Previous Article Next Article

Synthesis and biological evaluation of novel derivatives of gambogenic acid as anticancer agents

Author affiliations

Abstract

A series of novel derivatives of gambogenic acid (GNA) were synthesized and evaluated for their in vitro antiproliferative activity against four kinds of tumor cell lines. The compounds 3c, 3f, 3h and 3j displayed potent antiproliferative activities (IC50: 1.41–2.94 μM on A549 cells, 0.98–1.95 μM on HepG2 cells, 0.45–2.86 μM on panc-1 cells and 1.13–2.65 μM on U251 cells), which are superior to those of the parent compound GNA. Note that 3f significantly affects the proliferation of tumor cells. Furthermore, 3f could induce S phase cell cycle arrest and decrease the ratio of Bc1-2/Bax in HepG2 cells. This suggests that 3f may serve as a potential lead compound for the development of new anticancer drugs.

Graphical abstract: Synthesis and biological evaluation of novel derivatives of gambogenic acid as anticancer agents

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 Sep 2014, accepted on 16 Oct 2014 and first published on 17 Oct 2014


Article type: Concise Article
DOI: 10.1039/C4MD00407H
Author version
available:
Download author version (PDF)
Med. Chem. Commun., 2015,6, 334-338

  •   Request permissions

    Synthesis and biological evaluation of novel derivatives of gambogenic acid as anticancer agents

    P. Huang, Z. Hu, L. He, X. Wang and Y. Wu, Med. Chem. Commun., 2015, 6, 334
    DOI: 10.1039/C4MD00407H

Search articles by author

Spotlight

Advertisements